Phase Ib study of decitabine in combination with gemcitabine in treatment of advanced soft tissue and bone sarcomas.

11550Background: Sarcomas are a heterogeneous group of tumors and are associated with high rates of metastases leading to poor prognosis. Numerous epigenetic changes including hypermethylation have...